Combined thyroid medications for TSH control in thyroid cancer
Part of Hormones & metabolism clinical trials.
This trial tests whether combining two thyroid hormone medications (levothyroxine and desiccated thyroid extract) can better keep your TSH in the target range after thyroid cancer surgery. The goal is to reduce the chance of the cancer coming back while managing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older (or between 18 and 70 for some parts).
- You have a type of thyroid cancer called differentiated thyroid cancer (DTC).
- You have already had surgery to remove your thyroid, with or without radioactive iodine treatment.
- Your doctor has told you that your risk of the cancer coming back is medium or high.
- You are currently taking levothyroxine, but your TSH (a thyroid hormone test) is still above the target level.
- You do not have serious heart conditions, other cancers, or conditions that affect stomach absorption.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called recombinant human thyroid stimulating hormone (rhTSH) can help prepare your body for radioactive iodine (131I) treatment, which aims to destroy any remaining or spreading thyroid cancer cells. It may be a good option if your thyroid cancer has come back or spread and you are able to have radioactive iodine therapy.
This study compares two ways of replacing thyroid hormone after radioactive iodine therapy for high-risk thyroid cancer. It aims to find which approach is more effective and better for patients.
This trial tests a combination of two drugs, sinibolimab (an immunotherapy) and lenvatinib (a targeted therapy), given before surgery to shrink locally advanced thyroid cancer that cannot be fully removed. The goal is to make the tumor removable and improve outcomes.
This study compares two ways of suppressing a hormone that can make thyroid cancer grow. It aims to find which method is better for people with advanced thyroid cancer that cannot be removed by surgery.
This study tests a new way of providing thyroid hormone therapy for people who still feel tired and other bothersome symptoms despite currently taking a standard thyroid pill (levothyroxine). It combines two types of thyroid hormone (T4 and T3) to see if it better relieves symptoms than the usual treatment.
This study tests whether it is safe to monitor small, low-risk thyroid cancers (1–4 cm) instead of removing the remaining thyroid tissue after initial surgery. It may help you avoid a second operation and lifelong medication if your cancer is truly low-risk.
Hear when a new Intermediate-to-High Risk Differentiated Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.